PlainRecalls
FDA Drug Critical Class I Terminated

Fluorouracil Injection, USP, 5 g / 100 mL (50 mg / mL), 100 mL fill in a 100 mL vial, Rx Only, Mfd. by: Fresenius Kabi, Lake Zurich, IL 60047. 63323-117-61 [Fresenius Kabi brand] and NDC 63323-117-69 [NOVAPLUS brand]

Reported: July 24, 2019 Initiated: June 28, 2019 #D-1489-2019

Product Description

Fluorouracil Injection, USP, 5 g / 100 mL (50 mg / mL), 100 mL fill in a 100 mL vial, Rx Only, Mfd. by: Fresenius Kabi, Lake Zurich, IL 60047. 63323-117-61 [Fresenius Kabi brand] and NDC 63323-117-69 [NOVAPLUS brand]

Reason for Recall

Presence of Particulate Matter; glass particulates

Details

Recalling Firm
Fresenius Kabi USA, LLC
Units Affected
14,016 vials
Distribution
Nationwide USA and Puerto Rico
Location
Melrose Park, IL

Frequently Asked Questions

What product was recalled?
Fluorouracil Injection, USP, 5 g / 100 mL (50 mg / mL), 100 mL fill in a 100 mL vial, Rx Only, Mfd. by: Fresenius Kabi, Lake Zurich, IL 60047. 63323-117-61 [Fresenius Kabi brand] and NDC 63323-117-69 [NOVAPLUS brand]. Recalled by Fresenius Kabi USA, LLC. Units affected: 14,016 vials.
Why was this product recalled?
Presence of Particulate Matter; glass particulates
Which agency issued this recall?
This recall was issued by the FDA Drug on July 24, 2019. Severity: Critical. Recall number: D-1489-2019.